Literature DB >> 21227728

Minimal evidence for a direct involvement of twisted gastrulation homolog 1 (TWSG1) gene in human holoprosencephaly.

Emily F Kauvar1, Ping Hu, Daniel E Pineda-Alvarez, Benjamin D Solomon, Amalia Dutra, Evgenia Pak, Brooke Blessing, Virginia Proud, Alan L Shanske, Cathy A Stevens, Jill A Rosenfeld, Lisa G Shaffer, Erich Roessler, Maximilian Muenke.   

Abstract

Holoprosencephaly (HPE) is the most common disorder of human forebrain and facial development. Presently understood etiologies include both genetic and environmental factors, acting either alone, or more likely, in combination. The majority of patients without overt chromosomal abnormalities or recognizable associated syndromes have unidentified etiologies. A potential candidate gene, Twisted Gastrulation Homolog 1 (TWSG1), was previously suggested as a contributor to the complex genetics of human HPE based on (1) cytogenetic studies of patients with 18p deletions, (2) animal studies of TWSG1 deficient mice, and (3) the relationship of TWSG1 to bone morphogenetic protein (BMP) signaling, which modulates the primary pathway implicated in HPE, Sonic Hedgehog (SHH) signaling. Here we present the first analysis of a large cohort of patients with HPE for coding sequence variations in TWSG1. We also performed fine mapping of 18p for a subset of patients with partial 18p deletions. Surprisingly, minimal evidence for alterations of TWSG1 was found, suggesting that sequence alterations of TWSG1 are neither a common direct cause nor a frequent modifying factor for human HPE pathologies.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21227728      PMCID: PMC3152819          DOI: 10.1016/j.ymgme.2010.12.008

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  65 in total

Review 1.  Mechanisms of ventral patterning in the vertebrate nervous system.

Authors:  Giuseppe Lupo; William A Harris; Katharine E Lewis
Journal:  Nat Rev Neurosci       Date:  2006-02       Impact factor: 34.870

Review 2.  High resolution melting applications for clinical laboratory medicine.

Authors:  Maria Erali; Karl V Voelkerding; Carl T Wittwer
Journal:  Exp Mol Pathol       Date:  2008-04-13       Impact factor: 3.362

3.  The organizer factors Chordin and Noggin are required for mouse forebrain development.

Authors:  D Bachiller; J Klingensmith; C Kemp; J A Belo; R M Anderson; S R May; J A McMahon; A P McMahon; R M Harland; J Rossant; E M De Robertis
Journal:  Nature       Date:  2000-02-10       Impact factor: 49.962

4.  Gene localization and syntenic mapping by FISH in the dog.

Authors:  A S Dutra; E Mignot; J M Puck
Journal:  Cytogenet Cell Genet       Date:  1996

5.  Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function.

Authors:  C Chiang; Y Litingtung; E Lee; K E Young; J L Corden; H Westphal; P A Beachy
Journal:  Nature       Date:  1996-10-03       Impact factor: 49.962

6.  The mammalian twisted gastrulation gene functions in foregut and craniofacial development.

Authors:  Anna Petryk; Ryan M Anderson; Michael P Jarcho; Irina Leaf; Cathy S Carlson; John Klingensmith; William Shawlot; Michael B O'Connor
Journal:  Dev Biol       Date:  2004-03-15       Impact factor: 3.582

7.  Clinical spectrum of SIX3-associated mutations in holoprosencephaly: correlation between genotype, phenotype and function.

Authors:  F Lacbawan; B D Solomon; E Roessler; K El-Jaick; S Domené; J I Vélez; N Zhou; D Hadley; J Z Balog; R Long; A Fryer; W Smith; S Omar; S D McLean; K Clarkson; A Lichty; N J Clegg; M R Delgado; E Levey; E Stashinko; L Potocki; M I Vanallen; J Clayton-Smith; D Donnai; D W Bianchi; P B Juliusson; P R Njølstad; H G Brunner; J C Carey; U Hehr; J Müsebeck; P F Wieacker; A Postra; R C M Hennekam; M-J H van den Boogaard; A van Haeringen; A Paulussen; J Herbergs; C T R M Schrander-Stumpel; A R Janecke; D Chitayat; J Hahn; D M McDonald-McGinn; E H Zackai; W B Dobyns; M Muenke
Journal:  J Med Genet       Date:  2009-04-02       Impact factor: 6.318

Review 8.  Neuroimaging advances in holoprosencephaly: Refining the spectrum of the midline malformation.

Authors:  Jin S Hahn; Patrick D Barnes
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-02-15       Impact factor: 3.908

Review 9.  Early pathogenesis of holoprosencephaly.

Authors:  Kohei Shiota; Shigehito Yamada
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-02-15       Impact factor: 3.908

10.  Proteolytic cleavage of Chordin as a switch for the dual activities of Twisted gastrulation in BMP signaling.

Authors:  J Larraín; M Oelgeschläger; N I Ketpura; B Reversade; L Zakin; E M De Robertis
Journal:  Development       Date:  2001-11       Impact factor: 6.868

View more
  4 in total

Review 1.  Holoprosencephaly: signaling interactions between the brain and the face, the environment and the genes, and the phenotypic variability in animal models and humans.

Authors:  Anna Petryk; Daniel Graf; Ralph Marcucio
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-10-22       Impact factor: 5.814

2.  TGIF Mutations in Human Holoprosencephaly: Correlation between Genotype and Phenotype.

Authors:  A A Keaton; B D Solomon; E F Kauvar; K B El-Jaick; A L Gropman; Y Zafer; J M Meck; S J Bale; D K Grange; B R Haddad; G C Gowans; N J Clegg; M R Delgado; J S Hahn; D E Pineda-Alvarez; F Lacbawan; J I Vélez; E Roessler; M Muenke
Journal:  Mol Syndromol       Date:  2011-05-18

3.  BOC is a modifier gene in holoprosencephaly.

Authors:  Mingi Hong; Kshitij Srivastava; Sungjin Kim; Benjamin L Allen; Daniel J Leahy; Ping Hu; Erich Roessler; Robert S Krauss; Maximilian Muenke
Journal:  Hum Mutat       Date:  2017-07-21       Impact factor: 4.878

4.  Cytogenetics and holoprosencephaly: A chromosomal microarray study of 222 individuals with holoprosencephaly.

Authors:  Tommy Hu; Paul Kruszka; Ariel F Martinez; Jeffrey E Ming; Emily K Shabason; Manu S Raam; Tamim H Shaikh; Daniel E Pineda-Alvarez; Maximilian Muenke
Journal:  Am J Med Genet C Semin Med Genet       Date:  2018-06       Impact factor: 3.908

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.